Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice
- 20 July 1992
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 141 (2) , 192-194
- https://doi.org/10.1016/0304-3940(92)90892-b
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonismLife Sciences, 1990
- β-N-Methylamino-l-alanineJournal of the Neurological Sciences, 1989
- Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐TetrahydropyridineJournal of Neurochemistry, 1987
- 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayNature, 1986
- Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouseNeuroscience Letters, 1985
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pigLife Sciences, 1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- ?-Carbolines as selective monoamine oxidase inhibitors:In vivo implicationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982